Remolta, Ailyn A.
HRN: 28-51-17 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2026
OXACILLIN 500MG (VIAL)
02/08/2026
02/14/2026
IV
500mg
Q6
Infected Wound Left Breast
Checking Initial Appropriateness